Position in BSX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$63,302,976
-$86,173,799 QoQ
Shares Held
1,483,200
-37.7% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#108
of 1,468 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Derivatives in BSX
reported options exposure · as of Sep 30, 2025CallValue
$19,526,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Medical Devices
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $218,961,143 across 6 Medical Devices names. BSX ranks #2 (28.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
834,900 | $75,525,054 | |
| 2 | BSX |
Boston Scientific Corp
This page
|
1,483,200 | $63,302,976 | |
| 3 | SYK |
Stryker Corp
|
159,100 | $50,091,044 | |
| 4 | NPCE |
NeuroPace Inc
|
1,505,125 | $23,916,436 | |
| 5 | AORT |
Artivion, Inc.
|
175,000 | $3,932,250 | |
| 6 | NSPR |
InspireMD, Inc.
|
3,133,405 | $2,193,383 |
All Filings in BSX
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,302,976 | 1,483,200 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $149,476,775 | 2,382,100 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $230,680,255 | 2,419,300 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $19,526,000 | 200,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $237,172,559 | 2,429,300 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $302,165,812 | 2,813,200 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $283,795,616 | 2,813,200 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $282,277,996 | 3,160,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $274,277,400 | 3,273,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $252,053,730 | 3,273,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $224,167,770 | 3,273,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $191,166,108 | 3,306,800 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $174,599,040 | 3,306,800 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $182,818,791 | 3,379,900 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $189,613,700 | 3,790,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $180,369,714 | 3,898,200 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $150,977,286 | 3,898,200 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $162,851,265 | 4,369,500 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $203,711,855 | 4,599,500 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $235,861,704 | 5,552,300 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $253,119,904 | 5,833,600 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $295,924,856 | 6,920,600 | Shares | Defined | 2021-08-16 | |
| 2021-06-30 | $10,690,000 | 250,000 | Call | Defined | 2021-08-16 | |
| 2021-03-31 | $267,481,190 | 6,920,600 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $234,501,850 | 6,523,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $185,215,333 | 4,847,300 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $170,188,703 | 4,847,300 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $158,167,399 | 4,847,300 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||